Table 2 Characteristics of hypertensive PLHIV at baseline (N = 3892)
Characteristics | Patients not enrolled in integrated HTN/HIV care (N = 2877) | Patients enrolled in integrated HTN/HIV care (N = 1015) | P value |
|---|---|---|---|
Sex | |||
 Male | 1,136 (39.5%) | 380 (37.4%) | 0.250 |
 Female | 1,741 (60.5%) | 635 (62.6%) | |
Mean Age (years) | 44.7 ± 10.1 | 50.1 ± 9.5 |  < 0.001 |
Age groups (years) | |||
 18–29 | 154 (5.4%) | 6 (1.0%) |  < 0.001 |
 30–39 | 801 (27.8%) | 123 (12.1%) | |
 40–49 | 1,038 (36.1%) | 361 (35.6%) | |
 50 and older | 884 (30.7%) | 525 (51.7%) | |
Mean baseline BP (mmHg) | |||
 Systolic ± SD | 143.0 ± 15.1 | 154.3 ± 20.0 |  < 0.001 |
 Diastolic ± SD | 92.6 ± 9.3 | 97.7 ± 13.1 |  < 0.001 |
ART duration | |||
  < 2 years | 588 (20.5%) | 47 (4.6%) |  < 0.001 |
 2—5yrs | 775 (27.0%) | 215 (21.2%) | |
 5—10yrs | 1,224 (42.6%) | 481 (47.4%) | |
  > 10yrs | 288 (10.0%) | 272 (26.8%) | |
Mean baseline CD4 count | 367.5 ± 296.8 | 325.7 ± 251.7 |  < 0.001 |
Baseline CD4 count categories | |||
  < 50 | 366 (12.7%) | 113 (11.1%) |  < 0.001 |
 50—< 100 | 216 (7.5%) | 64 (6.3%) | |
 100—< 200 | 378 (13.1%) | 192 (18.9%) | |
  > 200 | 1,917 (66.6%) | 646 (63.6%) | |
BMI(Kg/m.2) | |||
 Underweight (< 19.0) | 261 (9.6%) | 55 (5.4%) |  < 0.001 |
 Normal weight (19.0—< 25.0) | 1,237 (45.3) | 353 (34.8%) | |
 Overweight (25.0—< 30.0) | 729 (26.7%) | 337 (33.2%) | |
 Obese (> = 30.0) | 503 (18.4%) | 270 (26.6%) | |
Baseline ART regimen | |||
 AZT-3TC-NVP | 974 (33.9%) | 431 (42.5%) |  < 0.001 |
 AZT-3TC-EFV | 347 (12.1%) | 188 (18.5%) | |
 TDF-3TC-NVP | 224 (7.8%) | 96 (9.5%) | |
 TDF-3TC-EFV | 1,010 (35.1%) | 240 (23.6%) | |
 Other | 320 (11.1%) | 60 (5.9%) | |